Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
Laura C. Chambers, Benjamin D. Hallowell, Andrew R. Zullo, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2334540-e2334540
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl
Honora Englander, Ashish P. Thakrar, Sarah M. Bagley, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 6, pp. 691-691
Closed Access | Times Cited: 12
Addiction Consultation Services for Opioid Use Disorder Treatment Initiation and Engagement
Jennifer McNeely, Scarlett S. Wang, Yasna Rostam‐Abadi, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1106-1106
Closed Access | Times Cited: 11
The first five years of implementing Missouri's medication first approach to opioid use disorder treatment: Plateaus, regressions, and underbellies of progress
Rachel P. Winograd, Brandon Park, Bridget Coffey, et al.
Journal of Substance Use and Addiction Treatment (2025) Vol. 170, pp. 209622-209622
Open Access | Times Cited: 1
A humanized monoclonal antibody attenuates fentanyl self-administration and reverses and prevents fentanyl-induced ventilatory depression in rhesus monkeys
Lindsey K. Galbo, Courtney Marecki, Caroline Kim, et al.
Psychopharmacology (2025)
Closed Access | Times Cited: 1
The association between buprenorphine doses above 16 milligrams and treatment retention in a multi‐payer national sample in the United States, 2014 to 2021
Erin J. Stringfellow, Huiru Dong, Seyedeh Nazanin Khatami, et al.
Addiction (2025)
Closed Access | Times Cited: 1
Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims
Kevin Y. Xu, Alex K. Gertner, Shelly F. Greenfield, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
A Systematic Review of State Office-Based Buprenorphine Treatment Laws Effective During 2022: Counseling, Dosage, and Visit Frequency Requirements
Barbara Andraka‐Christou, Olivia K. Golan, Michelle S. Williams, et al.
Substance Use & Addiction Journal (2024) Vol. 45, Iss. 2, pp. 278-291
Closed Access | Times Cited: 7
Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023
Samuel T. Savitz, Maria A Stevens, Bidisha Nath, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2024) Vol. 8, Iss. 3, pp. 308-320
Open Access | Times Cited: 5
Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention
Lakshit Jain, Jasleen Kaur, Shahana Ayub, et al.
World Journal of Psychiatry (2024) Vol. 14, Iss. 6, pp. 760-766
Open Access | Times Cited: 4
Improving access to buprenorphine for rural veterans in a learning health care system
Jessica J. Wyse, Katherine Mackey, Kim A. Kauzlarich, et al.
Health Services Research (2024) Vol. 59, Iss. S2
Closed Access | Times Cited: 4
The fentanyl made me feel like I needed more methadone”: changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl
Maria Bolshakova, Kelsey A. Simpson, Siddhi S. Ganesh, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Fentanyl Use Disorder: A Guide for Nurse Practitioners
Mary Ellen Biggerstaff, Kim Miker
The Journal for Nurse Practitioners (2025) Vol. 21, Iss. 3, pp. 105315-105315
Closed Access
Buprenorphine adherence among a prospective cohort of homeless-experienced adults with opioid use disorder
Danielle R. Fine, Natalia Critchley, Katherine Hart, et al.
Drug and Alcohol Dependence (2025) Vol. 270, pp. 112598-112598
Closed Access
Association Between Buprenorphine Adherence Trajectories, Health Outcomes, and Health Care Costs Among Medicaid Enrollees
Olajumoke A. Olateju, Chijioke Okeke, Mina Shrestha, et al.
Journal of Addiction Medicine (2025)
Closed Access
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review
Kathleen K. Adams, Kristin Waters, Diana M Sobieraj
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Interventions for opioid use disorder among adolescents: A systematic review
Suhaib Yehya
Heroin addiction and related clinical problems (2025) Vol. 27, Iss. 1, pp. 1-14
Closed Access
Outcome of Buprenorphine maintenance treatment among Indian females with opioid dependence: Report from a tertiary addiction treatment center
Piyali Mandal, Atul Ambekar, Hemant Choudhary, et al.
Indian Journal of Psychiatry (2025) Vol. 67, Iss. 3, pp. 303-309
Open Access
Emergency Medical Services Utilization of Medication for Opioid Use Disorder: A Narrative Review of the Literature and Analysis of Prehospital Buprenorphine Protocols
Kasha Bornstein, David Rayburn
Prehospital Emergency Care (2025), pp. 1-20
Closed Access
Initiation of extended-release buprenorphine in emergency department patients: A retrospective cohort study
Louisa Marion-Bellemare, Anita Srivastava, Julie Samson, et al.
The American Journal of Emergency Medicine (2025)
Closed Access
Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl
Bradley D. Stein, Flora Sheng, Brendan Saloner, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Optimizing buprenorphine treatment for pregnant individuals: challenges and opportunities
Yumei Zhong, Shanshan Liu, Xiaofeng Lv
American Journal of Obstetrics and Gynecology (2025)
Closed Access
Buprenorphine discontinuation and utilization of psychosocial services: a national study in the Veterans Health Administration
Emma N. Cleary, Angela L. Rollins, Alan B. McGuire, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Navigating nitazenes: A pharmacological and toxicological overview of new synthetic opioids with a 2-benzylbenzimidazole core
Marthe M. Vandeputte, Christophe P. Stove
Neuropharmacology (2025), pp. 110470-110470
Closed Access
Medication for Opioid Use Disorder and Treatment Retention Among Pregnant Individuals
Valerie S. Ganetsky, Noa Krawczyk, Alene Kennedy‐Hendricks
JAMA Network Open (2025) Vol. 8, Iss. 4, pp. e256069-e256069
Open Access
Social Listening for Patient Experiences With Stopping Extended-Release Buprenorphine: Content Analysis of Reddit Messages (Preprint)
Michael Gilbert, Ashlynn R. Daughton, Howard D. Chilcoat, et al.
(2025)
Closed Access
Page 1 - Next Page

Scroll to top